2. Infection

Infection

Infection

Related Products

PDF 70.44 MB

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N14861
    Neoviridogrisein Ⅱ 66002-40-2 98%
    Neoviridogrisein II has been used to resist Gram-positive bacteria and mycoplasma.
    Neoviridogrisein Ⅱ
  • HY-N14862
    Midecamycin A2 35457-81-9 98%
    Midecamycin A2 is a macrolide compound with strong anti-Gram-positive bacteria and weak anti-Gram-negative bacteria, mycobacteria and fungi activity.
    Midecamycin A2
  • HY-N14863
    Neoviridogrisein III 66184-96-1 98%
    Neoviridogrisein III has been used to resist Gram-positive bacteria and mycoplasma.
    Neoviridogrisein III
  • HY-N14864
    Midecamycin A3 36025-69-1 98%
    Midecamycin A3 is a macrolide compound with strong anti-Gram-positive bacteria and weak anti-Gram-negative bacteria, mycobacteria and fungi activity.
    Midecamycin A3
  • HY-N14865
    Midecamycin A4 36083-82-6 98%
    Midecamycin A4 is a macrolide compound with strong anti-Gram-positive bacteria and weak anti-Gram-negative bacteria, mycobacteria and fungi activity.
    Midecamycin A4
  • HY-N14866
    Monorden B 88929-18-4 98%
    Monorden B has the effect of arresting the cell cycle of Jurket cells in G1 and G2/M phases. Monorden B has anti-Aspergillus niger activity.
    Monorden B
  • HY-N14870
    Ostreogrycin B3 31508-69-7 98%
    Ostreogrycin B3 has anti-Gram positive bacterial activity.
    Ostreogrycin B3
  • HY-N14871
    Pyrronamycin A 189080-82-8 98%
    Pyrronamycin A has antibacterial activity against Gram-positive and negative bacteria such as Staphylococcus aureus, enterococcus, Escherichia coli, Klebsiella pneumoniae, Proteus, Shigella and Salmonella.
    Pyrronamycin A
  • HY-N14872
    Pyrronamycin B 189080-83-9 98%
    Pyrronamycin B has antibacterial activity against Gram-positive and negative bacteria such as Staphylococcus aureus, enterococcus, Escherichia coli, Klebsiella pneumoniae, Proteus, Shigella and Salmonella. Pyrronamycin B also has anti-tumor activity.
    Pyrronamycin B
  • HY-N14873
    Dienomycin A 27542-54-7 98%
    Dienomycin A has anti-Gram-positive bacteria and mycobacterium activities.
    Dienomycin A
  • HY-N14875
    Fumaryl-DL-alanine 541-89-9 98%
    Fumaryl-DL-alanine has anti-Gram-positive bacterial activity.
    Fumaryl-DL-alanine
  • HY-N14876
    20-Deoxysalinomycin 64003-50-5 98%
    20-Deoxysalinomycin is mainly against Gram-positive bacteria, especially against coccidia of poultry.
    20-Deoxysalinomycin
  • HY-N14877
    Enactin Ia 130640-30-1 98%
    Enactin Ia is found in the strain of Streptomyces roseoviridis. Enactin Ia has only weak antifungal activity.
    Enactin Ia
  • HY-N14878
    Enactin Ⅰb 137252-26-7 98%
    Enactin Ib is found in the strain of Streptomyces roseoviridis. Enactin Ib has only weak antifungal activity.
    Enactin Ⅰb
  • HY-N14880
    Oudenone 31323-50-9 98%
    Oudenone is an oxygen-containing heterocyclic antibiotic. Oudenone has weak antibacterial and fungal activity. Oudenone has antihypertensive effect on spontaneous hypertension in rats by intraperitoneal injection or oral administration.
    Oudenone
  • HY-N14881
    Monorden E 616899-79-7 98%
    Monorden E has the effect of arresting the cell cycle of Jurket cells in G1 and G2/M phases. Monorden E has anti-Aspergillus niger activity.
    Monorden E
  • HY-N14883
    Mureidomycin D 114797-07-8 98%
    Mureidomycin D is an antibiotic with anti-Pseudomonas aeruginosa activity.
    Mureidomycin D
  • HY-N14885
    Pyridindolol K1 189756-49-8 98%
    Pyridindolol K1 is an alkaloid antibiotic found in Str. Sp. K93-0711.
    Pyridindolol K1
  • HY-N14886
    Pyridindolol K2 189756-51-2 98%
    Pyridindolol K2 is an alkaloid antibiotic found in Str. Sp. K93-0711. Pyridindolol K2 can inhibit the adhesion of HL-60 cells.
    Pyridindolol K2
  • HY-N14887
    Phleomycin E 11031-13-3 98%
    Phleomycin E is a heteropeptide antibiotic. Phleomycin E has anti-Gram-positive bacteria, negative bacteria and mycobacterium effects. Phleomycin E extends the survival time of mice transplanted with Ehrman's ascites cancer. Phleomycin E inhibits airy entity carcinoma in mice with an IC50 of 0.31 μg/mL.
    Phleomycin E
Cat. No. Product Name / Synonyms Application Reactivity